Summary Previous work has shown that the lethal effects of glucocorticoids on the human lymphoblastoid cell line, CEM-C7, are antagonized by the simultaneous presence of 1-,B-D-arabinofuranosylcytosine (Ara-C). A possible cell cycle mechanism prompted further studies using flow microfluorimetry. We now report that (1) Ara-C (10-100nM) blocks cells in S-phase and (2) the block is reversible after the drug is removed. A second treatment protocol, in which glucocorticoid is added to cells recovering from the effects of 24h exposure to Ara-C, results in a clear synergism between the 2 drugs. This synergism is observed over a range of concentrations (5-100nM), but is most significant at low doses, where inhibition of cell growth by Ara-C occurs but cell killing is minimal. Prior treatment with Ara-C increases the number of cells killed in the presence of steroid during the period 12-24h after removal of the S-phase block. Combinations of Ara-C and steroid can thus be either synergistic or antagonistic, depending on the drug scheduling.
Glucocorticoids are an essential element in the primary treatment of acute lymphoblastic leukaemia (Simone, 1979) , yet the precise mechanism of their cytocidal action remains unclear. Studies of glucocorticoid action on human leukaemic cells based on the response of the patient to therapy, or on cells isolated from patients who have been treated, are now more difficult because of the virtually universal use of the multi-drug schedules that have proved so successful in leukaemia therapy. As an alternative to the use of material obtained directly from the patient, a glucocorticoidsensitive clone (C7) isolated from the human leukaemic cell line CCRF-CEM (Foley et al., 1965) has provided a suitable model system for the investigation of glucocorticoid action on human leukaemic cells (Norman et al., 1981) .
Use of the CEM-C7 system to study cytotoxicity in vitro has revealed interactions between glucocorticoids and other anti-leukaemic drugs which may be of importance clinically, and has also provided some insight into the mechanism of glucocorticoid action (Norman et al., 1978; Gledhill & Norman, 1981b) . One of the drugs tested was the pyrimidine nucleoside analogue 1-fl-D-arabinofuranosylcytosine (cytosine arabinoside, Ara-C). When CEM-C7 cells were exposed to prednisolone and Ara-C according to a protocol whereby Ara-C was present during the final 24 h of a 48 h incubation with the steroid, the observed decrease in cloning efficiency was less than predicted from the toxicity of each drug when used alone (Gledhill & Norman, 1981b) . Furthermore, the antagonistic interaction was still apparent when using low concentrations of Ara-C which were themselves non-toxic, indicating that it was Ara-c, not prednisolone, which was responsible for the antagonism.
One explanation of this antagonism could be that Ara-C reversibly blocks some CEM-C7 cells in Sphase of the cell cycle, without killing them, and that in this state the cells are protected from the lethal effect of steroid. Studies with Ara-C in other cell systems have shown that the drug is capable of inhibiting DNA synthesis without killing the cells (Graham & Whitmore, 1970a; Preisler et al., 1979) and that the S-phase block can be reversed after removal of the drug (Tobey & Crissman, 1972; Yataganas et al., 1974) . We therefore wished to determine (1) whether or not Ara-C blocked CEM-C7 cells in S-phase, (2) whether any S-phase block was reversible, and if so (3) whether cells released from the block would have an increased sensitivity to glucocorticoid-induced cell killing. A preliminary account of part of this work has already been given (Gledhill & Norman, 1981a (Norman et al., 1978) . The day before the start of each experiment, cell aliquots were centrifuged (500 g) and resuspended in fresh medium at concentrations of 2-3 x i05ml-P. The cells were first treated for 24 h with steroid alone, since previous studies (Harmon et al., 1979) demonstrated a lag period of about 20 h before cell killing began. The cells were then treated for a further 24h in the presence of steroid plus Ara-C. In addition to an untreated control, the effects of steroid alone and Ara-C alone were also measured. One flask was used for each control and drug concentration.
Protocol 2 Cells were exposed to Ara-C alone for 24h, Ara-C was removed by washing once in drugfree medium, and the cells were resuspended in fresh medium containing steroid for a further period of culture. Cytosine arabinoside caused inhibition of cell growth during 24 h, so after removal of the drug, cell concentrations in control and Ara-C treated cultures were readjusted to the same value, 4-5 x 105 ml-'. Measurement of Ara-C induced cell killing was made directly after treatment with the drug.
Measurement of viability
Plating efficiency Colony-forming ability was measured by plating cells in agarose gels with a feeder layer of human fibroblasts (SAL MAT) (Norman et al., 1978 
Results
Effects of cytosine arabinoside on the cell cycle of CEM-C7 cells CEM-C7 cells were incubated with Ara-C (10-100nM) for 24h. After this time aliquots were taken for DNA analysis by flow microfluorimetry (FMF).
In the experiments shown in Figure 1 , 10nM Ara-C caused only partial inhibition of cell growth (38%) and had only a small effect on the FMF pattern. At 20nM there was some accumulation of cells in the later part of S-phase. As the Ara-C concentration increased, cells accumulated earlier in S-phase, and at lOOnM Ara-C the cells were blocked at the G1/S interface. Prednisolone blocks CEM-C7 cells in G, phase of the cell cycle (Harmon et al., 1979) , but when Ara-C was added to cells during the final 24 h of a 48 h incubation with steroid (protocol 1), the Sphase blockage induced by Ara-C was virtually identical to that observed in the absence of steroid (data not shown). These results were similar to those obtained with prednisolone and 6-mercaptopurine-a combination which is also antagonistic when used according to protocol (Norman et al., 1978; Gledhill & Norman, 1981b) .
Reversibility of the S-phase block induced hr cytosine arabinoside To investigate the reversibility of the Ara-C effect on CEM-C7 cells, FMF patterns were obtained for cells that had been exposed to Ara-C for 24 h, washed free of the drug, and then re-incubated in drug-free medium. Data for 40 nM Ara-C are given in (d) 40 nM (e) 50 nM and (f) 100 nM Ara-C. Cells were counted before and after treatment with Ara-C and the inhibitory effect of Ara-C on cell growth was expressed as a percentage of the increase in cell number in control culture. Cell growth was inhibited by 38% at 10nM, 61% at 20nM, 76% at 40nM, 80% at 5OnM and 94% at 100nM.
Figure 2. Two hours after the drug had been removed there was some evidence of passage through S-phase. Samples taken 5, 8 and 1lh after washing demonstrated continued movement of cells through S-phase and into cell division. Viability of Ara-C treated cells, measured by nuclear pyknosis, remained > 90% throughout the period of the experiment. The number of cells in mitosis was decreased relative to control immediately after Ara-c treatment, but increased to levels greater than control at 8h and llh, thus confirming the results obtained with FMF (Table I) .
Interaction of glucocorticoids and cytosine arabinoside Protocol 2 was designed to determine whether or During the experiment described in Figure 2 samples were wet-fixed and stained (see Methods) and analysed for morphologically viable cells and for cells in mitosis. Letters in parentheses refer to the FMF patterns in Figure   2 . Relative fluorescence intensity (channel no.) Figure 2 Reversibility of Ara-C-induced inhibition of DNA synthesis. CEM-C7 cells were treated with Ara-C (40nM) for 24h. An aliquot was taken for DNA analysis by flow microfluorimetry, while other Ara-C treated cells were washed and re-incubated in drug-free medium. The FMF pattern for control cells (a) is compared with the pattern immediately after Ara-C treatment (b) and with patterns obtained (c) 2 h (d) 5 h (e) 8 h and (f) 11 h after removal of the drug. not the glucocorticoid-induced cell killing could be increased by first blocking CEM-C7 cells in a state where they were protected from the lethal effect of glucocorticoid, removing the block, and then exposing the partially synchronised cells to steroid. Protocol 2 dose/response curves were produced by treating CEM-C7 cells with a range of Ara-C concentrations (5-100nM) for 24h, washing them free of the drug, and then re-incubating in a medium containing prednisolone (10-6M) for a further 48 h. The predicted cell survival after exposure to both drugs was taken to be the product of the survival after each drug alone, SA.SB (Table  II) . The dose/response curves from one such protocol 2 experiment are shown in Figure 3 . It was found that the interaction of Ara-C and prednisolone, when combined according to protocol 2. was synergistic over the whole range of concentrations used.
The synergistic interaction was reproducible in 4 dose/response experiments, and the results of all these experiments, together with results from Figure  5 , are incorporated into Figure 4 . The difference between predicted and measured cell survival Figure 3 Dose/response curves for CEM-C7 cell survival (measured by plating efficiency) after 24 h treatment with Ara-C alone (0) and for cells treated with prednisolone (106 M) after 24h prior exposure to Ara-C (0). Each point is the mean (± s.e.) of 4-5 dishes, using cells taken from 1 flask. The curves are compared with the theoretical curve (-) calculated from the cell survival after treatment with each drug alone (see Table II ).
(SAB-SA.SB) was greatest in conditions where the predicted cell survival (SA.SB) was highest. The slope of the regression line, however, indicates that the number of cells found to survive the drug combination was consistently about half that predicted for all values of SA SB* Effect of cytosine arabinoside on the time course of steroid-induced cell killing Prednisolone-induced cell killing was measured during the 3 days following treatment of cells with 10 nM Ara-C, a dose which was non-lethal when used alone (SB= 1) but was found to be capable of increasing the amount of cell killing in the presence of steroid. Prior exposure to Ara-C increased cell killing throughout the 3 days ( Figure 5A ), but the shapes of the two curves in Figure 5A suggested that the main effect of Ara-C occurred during the first 24h of culture with steroid.
Previous work (Harmon et al., 1979) had shown that there is a lag period of about 20 h before dexamethasone begins to reduce the cloning efficiency of CEM-C7 cells, so the effect of prior exposure to Ara-C (10nM) on the lag phase after dexamethasone treatment was investigated in more detail ( Figure 5B ). In this experiment, lOnM Ara-C inhibited cell growth by about 86% but was again non-lethal when used alone. The survival curves show that prior exposure to 10 nM Ara-C reduced the lag period before cell killing in the presence of steroid could be measured from about 18 h to about 12 h, but it did not completely abolish the lag phase.
Discussion
Cytosine arabinoside has proved to be of considerable value in the treatment of leukaemia (Rivera et al., 1980a, b; Keating et al., 1981; Early et al., 1982) but, as with glucocorticoids, there is some doubt as to the exact mechanism of its cytocidal action. The nucleotide derivative, Ara-CTP, is a potent inhibitor of DNA synthesis (Cozzarelli, 1977) and Ara-C is specifically toxic to cells in S-phase of the cell cycle (Bhuyan et al., 1973; Meyn et al., 1980) . There is evidence for blocking of DNA synthesis by competitive inhibition of DNA polymerase (Graham & Whitmore, 1970b) and by chain termination after incorporation of Ara-CTP into DNA (Momparler, 1972 (Momparler, , 1974 . Inhibition of DNA synthesis alone does not necessarily result in cell death (Graham & Whitmore, 1970a; Priesler et al., 1979) but there is some evidence for a relationship between the amount of Ara-C incorporated into DNA and loss of clonogenicity by lymphoid cells in vitro Major et al., 1981) . Inhibition of DNA synthesis by Ara-C results in chromosome damage, and the extent of this damage can also be correlated with cell killing (Benedict et al., 1970; Karon et al., 1972; Moore, 1981; Jones et al., 1976) . Woodcock et al. have proposed that double replication of some DNA segments following removal of the Ara-C block causes the chromosome aberrations which lead to abnormal segregation of chromatids at mitosis and cell death (Woodcock et al., 1979; Woodcock & Cooper, 1981) .
Treatment of CEM-C7 cells in vitro with Ara-C and prednisolone according to protocol 1, in which both drugs were present during the final 24 h of a 48 h incubation with steroid, resulted in cell killing which was less than predicted from the toxicity of each drug alone (Gledhill & Norman, 1981b) . The antagonism was evident at Ara-C doses .. m.-r. that were capable of inhibiting cell growth but were not lethal when used alone, suggesting that the antagonism was due to modulation of steroid potency by Ara-C.
Our working hypothesis for the mechanism of protocol 1 antagonism proposes that Ara-C reversibly blocks some CEM-C7 cells in S-phase of the cell cycle, where they are protected from the lethal effects of steroid. FMF patterns presented above (Figure 1 ) have confirmed that treatment of CEM-C7 cells with Ara-C causes accumulation of cells in S-phase of the cell cycle. Low doses of Ara-C (10-50 nM) allowed entry of cells into S-phase but inhibited completion of S-phase, while 100 nM Ara-C blocked virtually all DNA synthesis. Similar changes in FMF patterns according to Ara-c dose have been observed with other cell systems (Fried et al., 1981) . Other data (not shown) also confirmed the predominance of the Ara-C effects over those induced by steroid. When Ara-C was removed from the cultures and cells were reincubated in drug-free medium there was a reversal of its effect on DNA synthesis-the cells were able to complete S-phase and enter mitosis (Figure 2) .
Since the corollary to the hypothesis stated above is that cells should be more steroid-sensitive in phases of the cell cycle other than S-phase, an attempt was made to test this prediction by altering the timing of drug addition so that steroid was added to cells that had been exposed to Ara-C for the previous 24 h (protocol 2). Under these conditions the interaction observed became one of synergism rather than antagonism (Figure 3) .
After removal of Ara-C by washing, a period of about 5h elapsed before any cells reached mitosis. Analysis 8 h and 11 h after removal of Ara-C confirmed that a greater than normal number of cells had entered mitosis, and there was then an increase in the number of cells in G1 (Figure 2) . Thus, the time required for synchronised cells to reach G1 phase corresponds with the time at which a fraction of the pre-treated cells are killed more rapidly than control cells (between 12h and 20h see Figure SB ), suggesting that lysis of synchronised cells is induced in the subsequent G1 phase.
This explanation would agree with other evidence that glucocorticoid-induced cell death occurs in G1 phase: (a) administration of glucocorticoids in vivo resulted in a decrease in the number of dividing leukaemic cells that were able to enter S-phase (Lampkin et al., 1969; Ernst & Killman, 1970) ; (b) Glucocorticoids inhibited progress from G1 into S in lymphocytes stimulated in vitro with PHA (Sloman & Bell, 1980) and had similar effects on other cells lines in vivo (Braunschweiser & Schiffer, 1979) aind in ritro (Bakke & Eilk-Nes, 1981) ; (c) Treatment of CEM-C7 cells with glucocorticoids caused an irreversible increase in the number of cells in G1 which were unable to form clones (Harmon et al., 1979) ; (d) Glucocorticoids also kill non-dividing thymocytes (Munck et al., 1979) and lymphocytes from patients with chronic lymphocytic leukaemia (Galili et al., 1982) which are in prolonged G1 or Go states.
What is not yet clear, however, is whether the entire process of steroid killing necessarily occurs in Gl, or whether an effect of steroid which is initiated in some other phase of the cell cycle eventually results in cell death when steroid is present during G1 phase. Since the doubling time of the cells (-20h ) is approximately equal to the time elapsed before steroid induces loss of cloning efficiency, the former mechanism would imply that a single G1 phase is insufficient for steroids to exert their effects. The synergism observed with Ara-C may indicate that the latter mechanism is correct, and the process of steroid killing is initiated during, or soon after, S-phase.
The data currently available for interactions between Ara-C and glucocorticoids are compatible with the hypothesis that the steroids are cell cycle specific. There are, however, other explanations that also fit the data. Synergism would occur in protocol 2 if the presence of steroid could potentiate minor damage caused by Ara-C to a degree which results in cell death. Such a mechanism would be similar to the synergism between glucocorticoids and various alkylating agents which has been observed in cells which are not lysed by glu,cocorticoids (Harrap et al., 1977;  Shepherd & Harrap, 1982; Tew et al., 1982) . Since both Ara-C and the alkylating agents are known to damage DNA, it is possible that glucocorticoids interfere with DNA repair mechanisms and so diminish the ability of cells to recover from exposure to these drugs.
The results demonstrating antagonism described previously (Gledhill & Norman, 1981b) , together with the synergistic interactions described in this paper, suggest that the effectiveness of a combination of Ara-C and prednisolone in leukaemia therapy could be influenced by the timing of drug administration. It is now important to determine whether or not the synergistic interactions can be reproduced and enhanced in vivo.
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